Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

被引：0
|
作者：
Peace, James H. [1 ]
Medeiros, Felipe A. [2 ]
Martin, Keith R. [3 ,4 ]
Vittitow, Jason L. [5 ]
Weinreb, Robert N. [2 ,6 ]
机构：
[1] United Med Res Inst, Inglewood, CA USA
[2] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA
[3] Addenbrookes Hosp, Eye Dept, Cambridge, England
[4] Cambridge NIHR Biomed Res Ctr, Cambridge, England
[5] Bausch Lomb, Clin Affairs, Bridgewater, NJ USA
[6] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3035
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Diurnal variation of intraocular pressure in patients with exfoliation glaucoma or primary open-angle glaucoma treated with timolol 0.5%
    Konstas, AGP
    Mantziris, DA
    Cate, EA
    Stewart, WC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2592 - 2592
  • [42] Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
    E D Sharpe
    C J Henry
    T K Mundorf
    D G Day
    J A Stewart
    J N Jenkins
    W C Stewart
    Eye, 2005, 19 : 35 - 40
  • [43] Latanoprostene Bunod 0.024% Significantly Reduces and Maintains Mean Diurnal Intra-Ocular Pressure (IOP) Compared to Latanoprost 0.005% in Subjects with Open Angle Glaucoma or Ocular Hypertension
    Katz, L. Jay
    Kaufman, Paul
    Ong, Tuyen
    Scassellati-Sforzolini, Baldo
    Vittitow, Jason
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [44] To Compare the Intraocular Pressure Lowering Efficacy and Cost Effectiveness of Latanoprost vs. Bimatoprost in Cases of Primary Open Angle Glaucoma and Ocular Hypertension
    Singh, Shaunik
    Singh, Gursatinder
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S49 - S49
  • [45] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
    Kaidi Wang
    Li Xu
    Zhilan Yuan
    Ke Yao
    Junmei Zhao
    Liang Xu
    Aiwu Fang
    Mingzhi Zhang
    Lingling Wu
    Jian Ji
    Jiamin Hou
    Qing Liu
    Xinghuai Sun
    BMC Ophthalmology, 14
  • [46] Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
    Wang, Kaidi
    Xu, Li
    Yuan, Zhilan
    Yao, Ke
    Zhao, Junmei
    Xu, Liang
    Fang, Aiwu
    Zhang, Mingzhi
    Wu, Lingling
    Ji, Jian
    Hou, Jiamin
    Liu, Qing
    Sun, Xinghuai
    BMC OPHTHALMOLOGY, 2014, 14
  • [47] Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
    Beckers, Henny J. M.
    Schouten, Jan S. A. G.
    Webers, Carroll A. B.
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 593 - 599
  • [48] Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma
    Netland, PA
    Weiss, HS
    Stewart, WC
    Cohen, JS
    Nussbaum, LL
    Abrams, D
    Schwartz, G
    Hughes, P
    Adelson, A
    Brink, M
    Myers, M
    Bahr, R
    Dowling, JL
    Richards, F
    Geltzer, A
    Hofmann, RJ
    SnadyMcCoy, L
    Bartnik, LA
    Beneke, J
    Barr, L
    Muroski, D
    Neal, J
    Clevenger, C
    Summitt, B
    Lee, A
    Cohen, J
    Riccio, KA
    Luechauer, A
    DuBiner, H
    Cribbs, S
    Laibovitz, R
    Neck, K
    Mundorf, T
    Otero, D
    Netland, PA
    Vivolo, DA
    Schwartz, L
    Carmichael, P
    Conner, R
    Nowinski, T
    Kesselring, J
    Bollenbach, A
    Foley, A
    Stewart, W
    Stewart, J
    Weiss, H
    Schwartz, A
    Latham, BD
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (04) : 465 - 477
  • [49] Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma (vol 15, pg 2255, 2014)
    Lorenz, K.
    Pfeiffer, N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2473 - 2473
  • [50] Efficacy and safety of unoprostone isopropyl 0.15% and latanoprost 0.005% in adjunctive therapy to timolol maleate 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Pfeiffer, N
    Yannoulis, N
    Mertz, B
    Cirkel, C
    Kapik, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S820 - S820
12345